APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Genetically Modified Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Genetically Modified Drug Industry Research Report 2026

Report ID 173994860522 December 2025136 pages

Choose your research edition.

Industry ResearchGenetically Modified Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetically Modified Drug Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Genetically Modified Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetically Modified Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetically Modified Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Genetically Modified Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Genetically Modified Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Genetically Modified Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Genetically Modified Drug include Takeda, Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Eli Lilly, Pfizer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Genetically Modified Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Genetically Modified Drug Market by Company

Takeda

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

Amgen

Pharming Group NV

LFB Biotechnologies SA

F. Hoffmann-La Roche

Abbott Laboratories

Genetically Modified Drug Segment by Type

Transgenic Animal

Transgenic Plant

Genetically Modified Drug Segment by Application

Hospital

Clinic

Genetically Modified Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Genetically Modified Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Genetically Modified Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Genetically Modified Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Genetically Modified Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Genetically Modified Drug Sales (k units) of Manufacturers (2021-2026) Table 7. Global Genetically Modified Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Genetically Modified Drug Revenue of Manufacturers (2021-2026) Table 9. Global Genetically Modified Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Genetically Modified Drug Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Genetically Modified Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Genetically Modified Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Genetically Modified Drug, Product Type & Application Table 14. Global Genetically Modified Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Genetically Modified Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Company Information Table 19. Takeda Business Overview Table 20. Takeda Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Takeda Genetically Modified Drug Product Portfolio Table 22. Takeda Recent Developments Table 23. Sanofi Company Information Table 24. Sanofi Business Overview Table 25. Sanofi Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sanofi Genetically Modified Drug Product Portfolio Table 27. Sanofi Recent Developments Table 28. Johnson & Johnson Company Information Table 29. Johnson & Johnson Business Overview Table 30. Johnson & Johnson Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Johnson & Johnson Genetically Modified Drug Product Portfolio Table 32. Johnson & Johnson Recent Developments Table 33. Novartis Company Information Table 34. Novartis Business Overview Table 35. Novartis Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Novartis Genetically Modified Drug Product Portfolio Table 37. Novartis Recent Developments Table 38. Merck & Co. Company Information Table 39. Merck & Co. Business Overview Table 40. Merck & Co. Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Merck & Co. Genetically Modified Drug Product Portfolio Table 42. Merck & Co. Recent Developments Table 43. Roche Company Information Table 44. Roche Business Overview Table 45. Roche Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Roche Genetically Modified Drug Product Portfolio Table 47. Roche Recent Developments Table 48. Eli Lilly Company Information Table 49. Eli Lilly Business Overview Table 50. Eli Lilly Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Eli Lilly Genetically Modified Drug Product Portfolio Table 52. Eli Lilly Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Pfizer Genetically Modified Drug Product Portfolio Table 57. Pfizer Recent Developments Table 58. GlaxoSmithKline Company Information Table 59. GlaxoSmithKline Business Overview Table 60. GlaxoSmithKline Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. GlaxoSmithKline Genetically Modified Drug Product Portfolio Table 62. GlaxoSmithKline Recent Developments Table 63. Baxter Company Information Table 64. Baxter Business Overview Table 65. Baxter Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Baxter Genetically Modified Drug Product Portfolio Table 67. Baxter Recent Developments Table 68. Amgen Company Information Table 69. Amgen Business Overview Table 70. Amgen Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Amgen Genetically Modified Drug Product Portfolio Table 72. Amgen Recent Developments Table 73. Pharming Group NV Company Information Table 74. Pharming Group NV Business Overview Table 75. Pharming Group NV Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pharming Group NV Genetically Modified Drug Product Portfolio Table 77. Pharming Group NV Recent Developments Table 78. LFB Biotechnologies SA Company Information Table 79. LFB Biotechnologies SA Business Overview Table 80. LFB Biotechnologies SA Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. LFB Biotechnologies SA Genetically Modified Drug Product Portfolio Table 82. LFB Biotechnologies SA Recent Developments Table 83. F. Hoffmann-La Roche Company Information Table 84. F. Hoffmann-La Roche Business Overview Table 85. F. Hoffmann-La Roche Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio Table 87. F. Hoffmann-La Roche Recent Developments Table 88. Abbott Laboratories Company Information Table 89. Abbott Laboratories Business Overview Table 90. Abbott Laboratories Genetically Modified Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Abbott Laboratories Genetically Modified Drug Product Portfolio Table 92. Abbott Laboratories Recent Developments Table 93. Global Genetically Modified Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Genetically Modified Drug Sales by Region (2021-2026) & (k units) Table 95. Global Genetically Modified Drug Sales Market Share by Region (2021-2026) Table 96. Global Genetically Modified Drug Sales by Region (2027-2032) & (k units) Table 97. Global Genetically Modified Drug Sales Market Share by Region (2027-2032) Table 98. Global Genetically Modified Drug Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Genetically Modified Drug Revenue Market Share by Region (2021-2026) Table 100. Global Genetically Modified Drug Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Genetically Modified Drug Revenue Market Share by Region (2027-2032) Table 102. North America Genetically Modified Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 104. North America Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 105. North America Genetically Modified Drug Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Genetically Modified Drug Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Genetically Modified Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 109. Europe Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 110. Europe Genetically Modified Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Genetically Modified Drug Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Genetically Modified Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Genetically Modified Drug Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Genetically Modified Drug Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Genetically Modified Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 119. South America Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 120. South America Genetically Modified Drug Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Genetically Modified Drug Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Genetically Modified Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Genetically Modified Drug Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Genetically Modified Drug Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 128. Global Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 129. Global Genetically Modified Drug Sales Market Share by Type (2021-2026) Table 130. Global Genetically Modified Drug Sales Market Share by Type (2027-2032) Table 131. Global Genetically Modified Drug Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Genetically Modified Drug Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Genetically Modified Drug Revenue Market Share by Type (2021-2026) Table 134. Global Genetically Modified Drug Revenue Market Share by Type (2027-2032) Table 135. Global Genetically Modified Drug Price by Type (2021-2026) & (US$/unit) Table 136. Global Genetically Modified Drug Price by Type (2027-2032) & (US$/unit) Table 137. Global Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 138. Global Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 139. Global Genetically Modified Drug Sales Market Share by Application (2021-2026) Table 140. Global Genetically Modified Drug Sales Market Share by Application (2027-2032) Table 141. Global Genetically Modified Drug Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Genetically Modified Drug Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Genetically Modified Drug Revenue Market Share by Application (2021-2026) Table 144. Global Genetically Modified Drug Revenue Market Share by Application (2027-2032) Table 145. Global Genetically Modified Drug Price by Application (2021-2026) & (US$/unit) Table 146. Global Genetically Modified Drug Price by Application (2027-2032) & (US$/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Genetically Modified Drug Distributors List Table 150. Genetically Modified Drug Customers List Table 151. Genetically Modified Drug Industry Trends Table 152. Genetically Modified Drug Industry Drivers Table 153. Genetically Modified Drug Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Genetically Modified Drug Product Image Figure 5. Global Genetically Modified Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Genetically Modified Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Genetically Modified Drug Sales (2021-2032) & (k units) Figure 8. Global Genetically Modified Drug Average Price (US$/unit) & (2021-2032) Figure 9. Transgenic Animal Product Image Figure 10. Transgenic Plant Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global Genetically Modified Drug Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Genetically Modified Drug, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Genetically Modified Drug Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Genetically Modified Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Genetically Modified Drug Sales by Region in 2025 Figure 19. Global Genetically Modified Drug Revenue by Region in 2025 Figure 20. North America Genetically Modified Drug Market Size by Country in 2025 Figure 21. North America Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 22. North America Genetically Modified Drug Revenue Market Share by Country (2021-2032) Figure 23. United States Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Genetically Modified Drug Market Size by Country in 2025 Figure 27. Europe Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 28. Europe Genetically Modified Drug Revenue Market Share by Country (2021-2032) Figure 29. Germany Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Genetically Modified Drug Market Size by Country in 2025 Figure 40. Asia Pacific Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Genetically Modified Drug Revenue Market Share by Country (2021-2032) Figure 42. China Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Genetically Modified Drug Market Size by Country in 2025 Figure 51. South America Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 52. South America Genetically Modified Drug Revenue Market Share by Country (2021-2032) Figure 53. Brazil Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Colombia Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Genetically Modified Drug Market Size by Country in 2025 Figure 58. Middle East and Africa Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Genetically Modified Drug Revenue Market Share by Country (2021-2032) Figure 60. Egypt Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Genetically Modified Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Genetically Modified Drug Sales Market Share by Type (2021-2032) Figure 66. Global Genetically Modified Drug Revenue Market Share by Type (2021-2032) Figure 67. Global Genetically Modified Drug Price (US$/unit) by Type (2021-2032) Figure 68. Global Genetically Modified Drug Sales Market Share by Application (2021-2032) Figure 69. Global Genetically Modified Drug Revenue Market Share by Application (2021-2032) Figure 70. Global Genetically Modified Drug Price (US$/unit) by Application (2021-2032) Figure 71. Genetically Modified Drug Value Chain Figure 72. Genetically Modified Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Genetically Modified Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Transgenic Animal
  • Transgenic Plant
Applications
  • Hospital
  • Clinic
Companies covered
  • Takeda
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • Amgen
  • Pharming Group NV
  • LFB Biotechnologies SA
  • F. Hoffmann-La Roche
  • Abbott Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Genetically Modified Drug Market Size (2021-2032)
  4. 2.2.2 Global Genetically Modified Drug Sales (2021-2032)
  5. 2.2.3 Global Genetically Modified Drug Market Average Price (2021-2032)
  6. 2.3 Genetically Modified Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Transgenic Animal
  9. 2.3.3 Transgenic Plant
  10. 2.4 Genetically Modified Drug by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Genetically Modified Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Genetically Modified Drug Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Genetically Modified Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Genetically Modified Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Genetically Modified Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Genetically Modified Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Genetically Modified Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Genetically Modified Drug, Established Date
  9. 3.9 Global Genetically Modified Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda
  2. 4.1.1 Takeda Company Information
  3. 4.1.2 Takeda Business Overview
  4. 4.1.3 Takeda Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Genetically Modified Drug Product Portfolio
  6. 4.1.5 Takeda Recent Developments
  7. 4.2 Sanofi
  8. 4.2.1 Sanofi Company Information
  9. 4.2.2 Sanofi Business Overview
  10. 4.2.3 Sanofi Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi Genetically Modified Drug Product Portfolio
  12. 4.2.5 Sanofi Recent Developments
  13. 4.3 Johnson & Johnson
  14. 4.3.1 Johnson & Johnson Company Information
  15. 4.3.2 Johnson & Johnson Business Overview
  16. 4.3.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Johnson & Johnson Genetically Modified Drug Product Portfolio
  18. 4.3.5 Johnson & Johnson Recent Developments
  19. 4.4 Novartis
  20. 4.4.1 Novartis Company Information
  21. 4.4.2 Novartis Business Overview
  22. 4.4.3 Novartis Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novartis Genetically Modified Drug Product Portfolio
  24. 4.4.5 Novartis Recent Developments
  25. 4.5 Merck & Co.
  26. 4.5.1 Merck & Co. Company Information
  27. 4.5.2 Merck & Co. Business Overview
  28. 4.5.3 Merck & Co. Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck & Co. Genetically Modified Drug Product Portfolio
  30. 4.5.5 Merck & Co. Recent Developments
  31. 4.6 Roche
  32. 4.6.1 Roche Company Information
  33. 4.6.2 Roche Business Overview
  34. 4.6.3 Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Roche Genetically Modified Drug Product Portfolio
  36. 4.6.5 Roche Recent Developments
  37. 4.7 Eli Lilly
  38. 4.7.1 Eli Lilly Company Information
  39. 4.7.2 Eli Lilly Business Overview
  40. 4.7.3 Eli Lilly Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Eli Lilly Genetically Modified Drug Product Portfolio
  42. 4.7.5 Eli Lilly Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer Genetically Modified Drug Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 GlaxoSmithKline
  50. 4.9.1 GlaxoSmithKline Company Information
  51. 4.9.2 GlaxoSmithKline Business Overview
  52. 4.9.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 GlaxoSmithKline Genetically Modified Drug Product Portfolio
  54. 4.9.5 GlaxoSmithKline Recent Developments
  55. 4.10 Baxter
  56. 4.10.1 Baxter Company Information
  57. 4.10.2 Baxter Business Overview
  58. 4.10.3 Baxter Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Baxter Genetically Modified Drug Product Portfolio
  60. 4.10.5 Baxter Recent Developments
  61. 4.11 Amgen
  62. 4.11.1 Amgen Company Information
  63. 4.11.2 Amgen Business Overview
  64. 4.11.3 Amgen Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Amgen Genetically Modified Drug Product Portfolio
  66. 4.11.5 Amgen Recent Developments
  67. 4.12 Pharming Group NV
  68. 4.12.1 Pharming Group NV Company Information
  69. 4.12.2 Pharming Group NV Business Overview
  70. 4.12.3 Pharming Group NV Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Pharming Group NV Genetically Modified Drug Product Portfolio
  72. 4.12.5 Pharming Group NV Recent Developments
  73. 4.13 LFB Biotechnologies SA
  74. 4.13.1 LFB Biotechnologies SA Company Information
  75. 4.13.2 LFB Biotechnologies SA Business Overview
  76. 4.13.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 LFB Biotechnologies SA Genetically Modified Drug Product Portfolio
  78. 4.13.5 LFB Biotechnologies SA Recent Developments
  79. 4.14 F. Hoffmann-La Roche
  80. 4.14.1 F. Hoffmann-La Roche Company Information
  81. 4.14.2 F. Hoffmann-La Roche Business Overview
  82. 4.14.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio
  84. 4.14.5 F. Hoffmann-La Roche Recent Developments
  85. 4.15 Abbott Laboratories
  86. 4.15.1 Abbott Laboratories Company Information
  87. 4.15.2 Abbott Laboratories Business Overview
  88. 4.15.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Abbott Laboratories Genetically Modified Drug Product Portfolio
  90. 4.15.5 Abbott Laboratories Recent Developments
5 Global Genetically Modified Drug Market Scenario by Region
  1. 5.1 Global Genetically Modified Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Genetically Modified Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Genetically Modified Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Genetically Modified Drug Sales by Region: 2027-2032
  5. 5.3 Global Genetically Modified Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Genetically Modified Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Genetically Modified Drug Revenue by Region: 2027-2032
  8. 5.4 North America Genetically Modified Drug Market Facts & Figures by Country
  9. 5.4.1 North America Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Genetically Modified Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Genetically Modified Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Genetically Modified Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Genetically Modified Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Genetically Modified Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Genetically Modified Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Genetically Modified Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Genetically Modified Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Genetically Modified Drug Market Facts & Figures by Country
  41. 5.7.1 South America Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Genetically Modified Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Genetically Modified Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Genetically Modified Drug Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Genetically Modified Drug Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Genetically Modified Drug Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Genetically Modified Drug Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Genetically Modified Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Genetically Modified Drug Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Genetically Modified Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Genetically Modified Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Genetically Modified Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Genetically Modified Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Genetically Modified Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Genetically Modified Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Genetically Modified Drug Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Genetically Modified Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Genetically Modified Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Genetically Modified Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Genetically Modified Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Genetically Modified Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Genetically Modified Drug Value Chain Analysis
  2. 8.1.1 Genetically Modified Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Genetically Modified Drug Production Mode & Process
  5. 8.2 Genetically Modified Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Genetically Modified Drug Distributors
  8. 8.2.3 Genetically Modified Drug Customers
9 Global Genetically Modified Drug Analyzing Market Dynamics
  1. 9.1 Genetically Modified Drug Industry Trends
  2. 9.2 Genetically Modified Drug Industry Drivers
  3. 9.3 Genetically Modified Drug Industry Opportunities and Challenges
  4. 9.4 Genetically Modified Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst